Scoping Review: The Effects of Interrupted Onabotulinumtoxin A Treatment for Chronic Migraine Prevention During the COVID-19 Pandemic
The COVID-19 pandemic had caused marked clinical deterioration in the migraine patient populations across US, Europe, and the Middle East. Strategies employed to circumvent this limitation included the adoption of remote consultation via telemedicine as well as the use of pharmacological agents such as CGRP antagonists. In the event of a reoccurrence of a worldwide pandemic, strategies should be implemented to prevent the cessation of needed treatment for those suffering from chronic migraine.
Authors
- Qing Zhao Ruan (ORCID: https://orcid.org/0000-0003-1586-1682)
- Daniel Pak (ORCID: https://orcid.org/0009-0005-5743-3741)
- R. Jason Yong (ORCID: https://orcid.org/0000-0001-6960-9621)
- Amanda Macone
- Abdulrazaq Albilali (ORCID: https://orcid.org/0000-0001-9308-3033)
- Timothy R. Deer (ORCID: https://orcid.org/0000-0001-8907-7730)
- Christopher Louis Robinson (ORCID: https://orcid.org/0000-0002-6276-9056)
- Sait Ashina (ORCID: https://orcid.org/0000-0003-3973-6640)
- Moises Dominguez (ORCID: https://orcid.org/0000-0001-9828-4651)
- Jamal Hasoon (ORCID: https://orcid.org/0000-0001-8227-1864)
- Sudhir Diwan (ORCID: https://orcid.org/0000-0002-1245-9033)
- Amitabh Gulati (ORCID: https://orcid.org/0000-0003-1654-8639)
Institutions
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- Cornell University (US)
- Lenox Hill Hospital (US)
- King Saud University (SA)
- The Spine & Nerve Centers of the Virginias (US)
- Weill Cornell Medicine (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Journal of Pain Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/jpr.s485548
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00